Article
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.
Journal of clinical microbiology - 1 Apr 2001
Cunningham S, Ank B, Lewis D, Lu W, Wantman M, Dileanis J A, Jackson J B, Palumbo P, Krogstad P, Eshleman S H
Abstract excerpt
The ViroSeq HIV-1 Genotyping System is a commercially available, integrated sequence-based system for analysis of human immunodeficiency virus type 1 (HIV-1) drug resistance. We evaluated the performance of this system by analyzing HIV-1 in pediatric plasma samples. Plasma samples from children 4 months to 17 years of age were obtained from a clinical trial protocol (PACTG 377). Children in PACTG 377 were...
Topics
- Adolescent
- Anti-HIV Agents
- Child
- Child, Preschool
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Genotype
- HIV Infections
- HIV Protease
- HIV Reverse Transcriptase
